期刊文献+

腹膜透析患者转血液透析原因及预后分析 被引量:3

Causes and prognosis of patients transferring from peritoneal dialysis to hemodialysis
下载PDF
导出
摘要 目的分析腹膜透析患者转血液透析的原因,并探讨影响其预后的因素。方法回顾性分析上海长征医院1999年至2008年39例腹膜透析患者转血液透析的原因,并分析在我院行血液透析的23例患者的预后。结果共有39例腹膜透析患者转血液透析,腹膜透析治疗平均时间(14.4±16.3)月。转血液透析的原因为:透析不充分(30.8%)、技术失败(28.2%)、腹膜透析相关感染(25.6%)、失超滤(10.3%)。在我院行血液透析的23例患者中有12例死亡,11例维持性血液透析治疗。死亡原因主要为心脑血管事件和感染,糖尿病患者平均存活时间明显低于慢性肾炎患者。结论腹膜透析患者转血液透析的主要原因是透析不充分、技术失败和腹膜透析相关感染。原发病类型可能影响转血液透析后患者存活时间,糖尿病肾病患者预后较慢性肾炎患者差。 Objective To analyze the causes and prognosis of patients transferring from peritoneal dialysis to hemodialysis. Methods We retrospectively investigated the causes of transferring from peritoneal dialysis to hemodialysis in 39 patients between 1999 and 2008, and analyzed the prognosis of 23 patients transferred in our hospital. Results In the 39 peritoneal dialysis patients transferred from peritoneal dialysis to hemodialysis, the average peritoneal dialysis time was 14.4±16.3 months, and the reasons for the transfer were dialysis insufficiency (30.8%), mechanical complications (28.2%), peritoneal dialysis related infection (25.6%) and ultrafiltration failure (10.3%). Twenty-three patients were transferred to hemodialysis in our hospital, of which 12 patients died and hemodialysis continued in 11 patients. The major causes of death were cardiocerebrovascular events and infection. Diabetic patients had worse prognosis than patients with glomerulonepthritis. Conclusion The main causes of transferring to hemodialysis were dialysis insufficiency, mechanical complications and peritoneal dialysis related infection. Primary disease leading to renal failure affects the prognosis of patients transferred from peritoneal dialysis to hemodialysis. Patients with diabetic nephropathy have worse prognosis than patients with glomerulonepthritis.
出处 《中国血液净化》 2008年第11期588-590,共3页 Chinese Journal of Blood Purification
关键词 腹膜透析 血液透析 糖尿病肾病 Peritoneal dialysis Hemodialysis Diabetic nephropathy
  • 相关文献

参考文献4

  • 1Dell'Aquila R, Chiaramonte S, Rodighiero MP, et al. Rational choice of peritoneal dialysis catheter[J]. Perit Dial Int, 2007, 27:S119-125.
  • 2Panagoutsos S, Kantartzi K, Passadakis P, et al. Timely transfer of peritoneal dialysis patients to hemodialysis improves survival rates[J]. Clin Nephrol, 2006, 65:43-7.
  • 3Hideki Kawanishi, Misaki Moriishi. Clinical effects of combined therapy with peritoneal dialysis and hemodialysis [J]. Perit Dial Int, 2007, 27:S126-129.
  • 4Hoshi H, Nakamoto H, Kanno Y, et al. Long-term follow-up of patients treated with a combination of continuous ambulatory peritoneal dialysis and hemodialysis[J]. Adv Petit Dial. 2006, 22:136-40.

同被引文献32

  • 1黎敏,吕蓓,黄秀嫦,黄玉云,冯明开.云南白药气雾剂外用治疗静脉炎疗效观察[J].当代护士(中旬刊),2004,11(5):11-12. 被引量:15
  • 2胡进访红,贾伟,温学.外用金黄膏抗感染的实验研究[J].中国基层医药,2004,11(6):696-697. 被引量:17
  • 3周玖瑶,李锐,廖雪珍,廖惠芳.麻仁润肠口服液对肠道及排便的作用的实验研究[J].广州中医药大学学报,1996,13(2):36-38. 被引量:6
  • 4付纲,韩庆烽,汪涛.腹膜透析置管术[J].中国血液净化,2007,6(3):120-121. 被引量:20
  • 5Dell Aquila R,Chiaramonte S,Rodighiero MP,et al.Rational choice of peritoneal dialysis catheter[J].perit Dial Int,2007,27(6):119-125.
  • 6National Institute of Health: National Institute of Diabetes and Digestive and Kidney Diseases. US renal data system: 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States[ EB/OL ].[ 2014-11-17 ]. http: //www. usrds.org/atlas 12.aspx.
  • 7Yu AW, Chou KF, Ho YW, et al. Development of the "peritoneal dialysis first" model in Hong Kong [ J ]. Perit Dial Int, 2007, 27 Suppl 2: S53-55.
  • 8Giuseppe P, Pietro P, Lucia DV, et al. International study of health care organization and financing for renal replacement therapy in Italy : an evolving reality [ J ]. Int J Health Care Finance Econ, 2007, 7( 2/3 ): 201-215.
  • 9Shuniehi F, Chikao Y, Yasuaki H, et al. The organization and financing of end-stage renal disease treatment in Japan [ J ]. Int J Health Care Finance Econ, 2007, 7( 2/3 ): 217-231.
  • 10De Vecchi AF, Dratwa M. Heahhcare systems and end-stage renal disease therapies- an international review: cost and reimbursement/funding of ESRD therapies [ J ]. Nephrol Dial Transpl, 1999, 14(6): 31-41.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部